The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer

Lung Cancer

Volumn 46, Issue 2, 2004, Pages 227-232

  Martin Ucar, Antonio E ^a   Waller, David A ^a   Atkins, Jane L ^a   Swinson, Daniel ^b   O'Byrne, Ken J ^b   Peake, Mick D ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Generalist; Resection rate; Specialist; Surgical outcomes

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; HOSPITAL PATIENT; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PRIORITY JOURNAL; THORAX SURGERY; TREATMENT OUTCOME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HOSPITAL MORTALITY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT CARE TEAM; PROFESSIONAL COMPETENCE; RETROSPECTIVE STUDIES; SPECIALTIES, MEDICAL; SURVIVAL ANALYSIS; THORACIC SURGERY; TREATMENT OUTCOME;

EID: 4944225534     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.03.010     Document Type: Article

References (27)

1. Joint Working Group of The British Thoracic Society and The Society of Cardiothoracic Surgeons of Great Britain and Ireland. The Critical Under-Provision of Thoracic Surgery in the UK. 2002.
2. Damhuis R.A., Schutte P.R. Resection rates and postoperative mortality in 7899 patients with lung cancer. Eur Respir J. 9:1996;7-10
3. Fry W.A., Menck H.R., Winchester D.P. The National Cancer Data Base report on lung cancer. Cancer. 77:1996;1947-1955
4. Janssen-Heijnen M.L., Gatta G., Forman D., Capocaccia R., Coebergh J.W. Variation in survival of patients with lung cancer in Europe. Eur J Cancer. 34(14):1998;2191-2196
5. Berrino R, Capocaccia R, Esteve J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A. Survival of cancer patients in Europe: the EUROCARE-2 study. IARC Scientific Publications No 151. Lyon, France: World Health Organisation, International Agency for Research on Cancer, European Commission, 1999.
6. Joslin CF, Rider L. Yorkshire Regional Cancer Organisation. Cancer in Yorkshire. Cancer Registry Special Report Series 1. Lung Cancer. Leeds: Yorkshire Regional Cancer Organisation, 1994.
7. Brown J.S., Eraut D., Trask C., Davison A.G. Age and the treatment of lung cancer. Thorax. 51:1996;564-568
8. Peake M.D., Thompson S., Lowe D., Pearson M.G. Ageism in the management of lung cancer. Age Ageing. 32(2):2003;171-177
9. Expert Advisory Group to the Chief Medical Officers of England and Wales. A policy framework for commissioning cancer services. London: Department of Health; 1995.
10. Silvestri G.A., Handy J., Lackland D., Corley E., Reed C.E. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest. 114:1998;675-680
11. Pearson F.G. Current status of surgical resection of lung cancer. Chest. 106:1984;337-395
12. Laroche C., Wells F., Coulden R., Stewart S., Goddard M., Lowry E., et al. Improving surgical resection rate in lung cancer. Thorax. 53:1998;445-449
13. Brundage M.D., Davies D., Mackillop W.J. Prognostic factors in non-small cell lung cancer. Chest. 122:2002;1037-1057
14. Society of Cardiothoracic Surgeons of Great Britain and Ireland. UK Thoracic Surgical Register; 1990-2000.
15. Waller DA. Surgery for non-small cell lung cancer - new trends. Lung Cancer 2001;34(Suppl 2):S133-6.
16. Onyeaka C.V.P., Martin-Ucar A.E., Edwards J.G., Rengarajan A., Atkins J.L., Muller S., et al. Early thoracoscopic excision is the best treatment of an indeterminate solitary pulmonary nodule. Lung Cancer. 41(Supp 2):2003;8
17. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest. 111(6):1997;1710-1717
18. Martin-Ucar A.E., Nicum R., Oey I., Edwards J.G., Waller D.A. En-bloc chest wall and lung resection for non-small cell lung cancer. Predictors of 60-day non-cancer related mortality. Eur J Cardiothorac Surg. 23(6):2003;859-864
19. Martin-Ucar A.E., Chaudhuri N., Edwards J.G., Muller S., Waller D.A. Can pneumonectomy for non-small cell lung cancer be avoided? An audit of parenchymal sparing lung surgery. Eur J Cardiothorac Surg. 21(4):2002;601-605
20. Treasure T., Utley M., Bailey A. Assessment of whether in-hospital mortality for lobectomy is a useful standard for the quality of lung cancer surgery: retrospective study. BMJ. 327(7406):2003;73-75
21. British Thoracic Society guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001;56(2):89-108.
22. Edwards J.G., Duthie D.J.R., Waller D.A. Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema. Thorax. 56:2001;791-795
23. Jazieh A.R., Hussain M., Howington J.A., Spencer H.J., Husain M., Grismer J.T., Read R.C. Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Ann Thorac Surg. 70:2000;1168-1171
24. Merrill R.M., Henson D.E., Barnes M. Conditional survival among patients with carcinoma of the lung. Chest. 116:1999;697-703
25. Hannan E.L., Radzyner M., Rubin D., Dougherty J., Brennan M.F. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery. 131:2002;6-15
26. Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001:19;345(3):181-8.
27. Birkmeyer J.D., Siewers A.E., Finlayson E.V., Stukel T.A., Lucas F.L., Batista I., et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 346:2002;1128-1137